Detailed Mechanism Funding and Narrative

Years of mechanism: 2008 2009

Details for Mechanism ID: 2804
Country/Region: Guyana
Year: 2009
Main Partner: Initiatives Inc.
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USAID
Total Funding: $0

Funding for Biomedical Prevention: Injection Safety (HMIN): $0

Continuing Activity using pipeline funds.

In FY 09, GSIP is focusing on finalizing activities in region 4, the capital, and initiating activities in Region 2

and the remote hinterland regions: 1, 8 and 9. Interventions include training of staff in the areas of safe

injection, waste management, commodity management and behavior change. Our efforts to support worker

and patient safety concentrate on ensuring injection safety practices and systems are integrated at the

facility, regional and central level. This includes commodity management, training curricula and capacity

development; sharps waste management guidelines and procedures, recording systems for vaccination and

needle stick injury, PEP coverage, monitoring and data analysis tools and process, and rational injection

use. At the central level it means inclusion of orals as first line treatment for standard treatment guidelines,

integration of IS training into pre and in-service professional and para-professional programs and building

capacity to present the material and monitoring of worker safety policy adherence. This work is conducted

with assistance from Ministries, PEPFAR projects, NAPS and professional training programs.

GSIP, in cooperation with MOH, completed two studies. The first was the final phase of a Prescription

Record Review which, based on our interventions, found that the proportion of cases receiving one or more

injections declined from the baseline 29% to 21% and prevalence of unnecessary injections declined from

34% to 30%, both statistically significant. As a corollary to the study, the training on medication counseling

for improving prescription adherence will be integrated into pharmacists and pharmacy assistant training.

The second was a Home Use Insulin and Safe Disposal Study designed to test out disposal options and full

supply of insulin syringes through staff counseling, guidance and provision of disposal containers and full

syringe supply. The results of both studies will be disseminated in FY 09 to assist MOH policy decisions.

GSIP is actively assisting the Regional Health Officers to develop strategies to implement the Health Care

Worker Policy launched by the Minister in December 2007. To date two regions have issued mandatory

policies for pre-exposure vaccinations and the Public Sector Union is actively encouraging workers to

adhere to pre and post exposure guidance and use of protective gear. All facilities have set up procedures

for documenting vaccinations and needle stick injuries. GSIP has also provided consumption data to help

regions and the central Ministry use data for budgeting for injection supplies.

In the area of waste management, GSIP has partnered with HAP (US Embassy) to get funding for the

construction of two DeMonfort incinerators at facilities with poor sharps management and as part of the

Waste Management Oversight Committee, GSIP) continues to provide technical assistance on disposal.

GSIP also assists all facilities to develop waste management plans.

GSIP is also working with the Standards and Technical Service Unit to incorporate injection safety

indicators into the MOH licensing process and to develop a demonstration project to certify facilities that

meet injection safety standards. The strategy for the certification process will also assist the Ministry to

design their licensing strategy.

GSIP completed its midterm assessment in February 2008 and will conduct a final assessment in 2009 in

the two sentinel regions, 6 and 10. The results of the midterm review were quite encouraging and are being

used to design, among other things, refresher training. A Behavior Change and Communication

assessment was also conducted to assess the effectiveness of our current communication activities and to

provide qualitative information to help us address factors that impede changes in practices and to expand

on our successes.

GSIP will be designing a pilot to link factors that affect staff motivation, such as worker safety, to

performance as an attempt to improve satisfaction and address retention, which challenges all public health

initiatives.

New/Continuing Activity: Continuing Activity

Continuing Activity: 13900

Continued Associated Activity Information

Activity Activity ID USG Agency Prime Partner Mechanism Mechanism ID Mechanism Planned Funds

System ID System ID

13900 3312.08 U.S. Agency for Initiatives, Inc. 6642 2804.08 Safe Medical $1,208,562

International Injections

Development

7468 3312.07 U.S. Agency for Initiatives, Inc. 4426 2804.07 Safe Medical $692,929

International Injections

Development

3312 3312.06 U.S. Agency for Initiatives, Inc. 2804 2804.06 Safe Medical $1,208,562

International Injections

Development

Table 3.3.05:

Subpartners Total: $0
John Snow, Inc: NA
Pathfinder International: NA
Academy for Educational Development: NA